지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.8
- 수록면
- 169 - 181 (13page)
이용수
초록· 키워드
오류제보하기
Diabetes mellitus is associated with inadequate bone health and quality and heightened susceptibility to fractures, even in patients with normal or elevated bone mineral density. Elevated advanced glycation end-products (AGEs) and a suppressed incretin pathway are among the mechanisms through which diabetes affects the bone. Accordingly, the present review aimed to investigate the effects of antidiabetic medications on bone quality, primarily through AGEs and the incretin pathway. Google Scholar, Cochrane Library, and PubMed were used to examine related studies until February 2024. Antidiabetic medications influence AGEs and the incretin pathway directly or indirectly. Certain antidiabetic drugs including metformin, glucagon-like peptide-1 receptor agonists (GLP-1RA), dipeptidyl-peptidase-4 (DDP-4) inhibitors, α-glucosidase inhibitors (AGIs), sodium-glucose co-transporter-2 inhibitors, and thiazolidinediones (TZDs), directly affect AGEs through multiple mechanisms. These mechanisms include decreasing the formation of AGEs and the expression of AGEs receptor (RAGE) in tissue and increasing serum soluble RAGE levels, resulting in the reduced action of AGEs. Similarly, metformin, GLP-1RA, DDP-4 inhibitors, AGIs, and TZDs may enhance incretin hormones directly by increasing their production or suppressing their metabolism. Additionally, these medications could influence AGEs and the incretin pathway indirectly by enhancing glycemic control. In contrast, sulfonylureas have not demonstrated any obvious effects on AGEs or the incretin pathway. Considering their favorable effects on AGEs and the incretin pathway, a suitable selection of antidiabetic drugs may facilitate more protective effects on the bone in diabetic patients.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
In Vivo Models for Incretin Research: From the Intestine to the Whole Body
Endocrinology and Metabolism
2016 .01
-
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
Journal of Obesity & Metabolic Syndrome
2021 .09
-
Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
대한뇌졸중학회지
2019 .01
-
Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
Endocrinology and Metabolism
2021 .08
-
Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
Endocrinology and Metabolism
2023 .02
-
Skeletal Fragility in Type 2 Diabetes Mellitus
Endocrinology and Metabolism
2018 .01
-
Diabetes and bone
Osteoporosis and Sarcopenia
2019 .01
-
Cardiovascular Outcome Trials of Incretin Therapy (Dipeptidyl Peptidase-4 Inhibitors/Glucagon-Like Peptide-1 Receptor Agonist)
지질·동맥경화학회지
2018 .01
-
Factors associated with Advanced Bone Age in Overweight and Obese Children
Pediatric Gastroenterology, Hepatology & Nutrition
2020 .01
-
Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World- Based Cohort Study (Diabetes Metab J 2019;43:640-8)
Diabetes and Metabolism Journal
2019 .01
-
The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes
Endocrinology and Metabolism
2019 .01
-
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond
Endocrinology and Metabolism
2023 .02
-
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Endocrinology and Metabolism
2016 .01
-
Mechanisms underlying diabetes-induced bone loss
International Journal of Oral Biology
2024 .06
-
혈당강하제 단독요법 투여 당뇨병환자에서 암발생률 평가: 후향적 코호트 연구
한국임상약학회지
2019 .01
-
Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts
Journal of Korean Medical Science
2021 .09
-
당뇨병 치료약제와 심혈관 질환
대한내과학회지
2021 .04
-
Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management
Endocrinology and Metabolism
2024 .04
-
Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study
Diabetes and Metabolism Journal
2022 .07
-
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Clinical and Molecular Hepatology
2022 .07
최근 본 자료
댓글(0)
0